|
|
Volumn 373, Issue 9671, 2009, Pages 1249-
|
|
Are new drugs for schizophrenia better than old ones?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
CLINICAL PRACTICE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
LETTER;
MEDICAL STUDENT;
PRIORITY JOURNAL;
PSYCHIATRIST;
SCHIZOPHRENIA;
UNSPECIFIED SIDE EFFECT;
CLASSIFICATION;
META ANALYSIS;
NOTE;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PSYCHIATRY;
STATISTICS;
TREATMENT OUTCOME;
METHODOLOGY;
TIME;
ANTIPSYCHOTIC AGENTS;
HUMANS;
META-ANALYSIS AS TOPIC;
PATIENT SELECTION;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES AS TOPIC;
PSYCHIATRY;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
RESEARCH DESIGN;
TIME FACTORS;
|
|
EID: 64049118720
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(09)60721-2 Document Type: Letter |
|
Times cited : (6)
|
|
References (2)
|
